ERGO Share PerformanceMore
|52 week high||172.00 08/01/16|
|52 week low||117.00 16/09/16|
|52 week change||-21.00 (-12.54%)|
|4 week volume||283,353 13/11/16|
Latest News« previous» nextMore
01/12/2016 - 07:39 StockMarketWire
Ergomed founder and chief executive Dr Miroslav Reljanovic has granted options over 100,000 ordinary shares from his p...
30/11/2016 - 16:35 RNS
29/11/2016 - 07:00 RNS
Statement regarding an acquisition of a company or assets
21/11/2016 - 08:10 StockMarketWire
Ergomed chairman Rolf Stahel will retire from the board at the end of his three year term of office on 31 March and wil...
21/11/2016 - 07:00 RNS
Notification of any change to a companys board e.g. appointments/resignations/changes to important functions or executive responsibilities of a director
16/11/2016 - 07:46 StockMarketWire
Ergomed has noted that its co-development partner Modus Therapeutics Holding AB has announced that following a plan...
16/11/2016 - 07:00 RNS
15/11/2016 - 16:33 RNS
Notification of major interests in shares
|Dividend yield||0 %|
Equity Research (ERGO)
Ergomed offers clinical trial and pharmacovigilance services to pharmaceutical companies, while also co-developing a product portfolio of therapies. It has unusually high revenue visibility, indeed...
Latest discussion posts More
“We will be hosting a webinar with the management of Ergomed tomorrow (Tuesday 27th September) at 11.15. There will be a presentation of the interim results lasting around ...”▼
Codes & Symbols
|Symbols||ERGO, LSE:ERGO, ERGO.L, ERGO:LN, LON:ERGO, XLON:ERGO|